2 min read
RAPS US Convergence
Meet Veristat at RAPS US Convergence 2025
Where Regulatory Excellence Meets Real-World Impact
Veristat is delighted...
Learn how our neuroscience team partner with sponsors across multiple therapeutic areas to accelerate trial success in complex neurological and psychiatric conditions. Our collaborative efforts have supported successful marketing applications, breakthrough therapy designations, and innovative trial solutions across rare and ultra-rare neurological disorders.
With 250+ clinical trials and projects completed in the past 10 years, we bring proven expertise to the most challenging neuroscience therapeutic areas. Our diverse trial experience includes drug, biologic, and diagnostic trials—including pediatric gene therapy, stroke cell therapy, and psychiatric NDA submissions, with more than 30% focused on rare or ultra-rare neurological diseases.
Pediatric gene therapy advancement
Strategic NDA/BLA submission support
Complex stroke therapy logistics
Rare disease trial management
Regulatory approval navigation (FDA, EMA, and regional agencies)
International family coordination
2 min read
Sep 10, 2025 Veristat Events
Veristat is delighted...
5 min read
Aug 28, 2025 Veristat Events